🇺🇸 FDA
Patent

US 10676452

Compound for the prophylaxis or treatment of organ damage

granted A61KA61K31/353A61P

Quick answer

US patent 10676452 (Compound for the prophylaxis or treatment of organ damage) held by Sulfateq B.V. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sulfateq B.V.
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/353, A61P, A61P13/12, A61P39/06